Glatt, S., Baeten, D., Baker, T., Griffiths, M., Ionescu, L., Lawson, A. D. G., . . . Shaw, S. (2018). Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: Evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammation. Ann Rheum Dis.
Style de citation ChicagoGlatt, Sophie, et al. "Dual IL-17A and IL-17F Neutralisation By Bimekizumab in Psoriatic Arthritis: Evidence From Preclinical Experiments and a Randomised Placebo-controlled Clinical Trial That IL-17F Contributes to Human Chronic Tissue Inflammation." Ann Rheum Dis 2018.
Style de citation MLAGlatt, Sophie, et al. "Dual IL-17A and IL-17F Neutralisation By Bimekizumab in Psoriatic Arthritis: Evidence From Preclinical Experiments and a Randomised Placebo-controlled Clinical Trial That IL-17F Contributes to Human Chronic Tissue Inflammation." Ann Rheum Dis 2018.